In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease.
“We found that 4-methylumbelliferone (4-MU) was able to block a key signaling pathway that triggers the development, growth and metastasis of prostate cancer,” said the study’s principal investigator Vinata B. Lokeshwar, Ph.D., professor of urology and director of the pilot and translational studies component of the Miami Clinical and Translational Science Institute. “The results were simply amazing.”
A new treatment strategy for stroke patients using a retrievable stent to open large arteries in conjunction with “clot-busting” medication can dramatically reduce long-term disability, according to a ground-breaking study published online April 17 in the New England Journal of Medicine.
Dan Brooks, an Indian River County firefighter and father of four, is not one to complain easily. Six years ago, he began experiencing pain on the side of his face. At first, it came and went, but over time the searing pain grew more intense and occurred more frequently.
The morning after being named the next President of the University of Miami, Julio Frenk, M.D., M.P.H., Ph.D., currently Dean of Harvard University’s T.H. Chan School of Public Health, met with clinical chairs and other leadership at the Miller School of Medicine.
A gene mutation causing a form of hereditary deafness has been identified by an international team of researchers led by Xuezhong Liu, M.D., Ph.D., Leonard M. Miller Professor and Vice Chair for Research in Otolaryngology and Director of the Center for Hereditary Deafness at the University of Miami Miller School of Medicine.
The 11th annual Miami CFAR Symposium, “Confronting HIV and Its Complications,” drew nearly 200 clinicians, researchers, educators, students and pharmaceutical company representatives to hear some of the world’s leading experts present the most current information available on HIV research and therapies.